Skip to content

Clinical study of freeze-dried human rabies vaccine (human diploid cells) versus Vero cell-purified freeze-dried vaccine after rabies exposure

Clinical study of freeze-dried human rabies vaccine (human diploid cells) versus Vero cell-purified freeze-dried vaccine after rabies exposure

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095761
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-01-22
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rabies

Interventions

Experimental group:Freeze-dried human rabies vaccine (human diploid cells)
Control group:Vero cell purified lyophilized vaccine

Sponsors

The Third People's Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 75 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 0-75 years who have been exposed to rabies for the first time; 2. Subjects who have not received rabies vaccine or rabies passive immunization preparations in the past; 3. Subjects’ informed consent is obtained and the informed consent form is signed; 4. Subjects can comply with the requirements of the clinical trial protocol and complete the follow-up as required; 5. Axillary temperature <= 37.0?.

Exclusion criteria

Exclusion criteria: If the exposed person has any of the following, he/she cannot participate in the study: 1. People prohibited from vaccination in the instructions; 2. People with immunodeficiency diseases.

Design outcomes

Primary

MeasureTime frame
Adverse events within 3 days from the first dose of vaccination to the completion of full immunization in all subjects;

Countries

China

Contacts

Public ContactXiang Tao

The Third People's Hospital of Chengdu

xt1142752929@126.com+86 138 8213 2616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026